|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Revenue | ||||
| Operating expenses: | ||||
| Research and development expenses | ||||
| Selling, general and administrative expenses | ||||
| Total operating expenses | ||||
| Operating loss | ||||
| Other income (expense): | ||||
| Interest income | ||||
| Fair value change - earnout and warrants | ||||
| Fair value change - earnout | ||||
| Fair value change - warrants | ||||
| Total fair value change - earnout and warrants | ||||
| Foreign exchange gains/(losses) | ||||
| Loss before tax | ||||
| Income tax expense (benefit) | ||||
| Loss for the year | ||||
| Other comprehensive income (loss) | ||||
| Unrealized gain on available-for-sale securities, net of tax | ||||
| Total comprehensive loss for the year, net of tax | ||||
| Net loss per ordinary share | ||||
| Basic | ||||
| Diluted | ||||
Loading...